TP53 has been shown to regulate the PD-1/PD-L1 axis in lung cancer studies, with IHC p53 positivity being associated with higher PD-L1 tumor cell expression31,32—a finding which was not confirmed in the case of breast cancer and TP53 mutations33. This evidence concerns the gene CD274 and lung carcinoma.